Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong · Delayed Price · Currency is HKD

1.350

0.00 (0.00%)

Sep 9, 2026, 3:48 PM HKT

HKG:2170 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	260.68	233.27	299.11	207.98	140.9	107.3
Revenue Growth	11.75%	-22.01%	43.82%	47.60%	31.32%	32.29%
Gross Profit	139.75	123.61	136.22	91.35	59.53	51.15
Operating Income	-145.03	-210.79	-267.79	-241.67	-216.04	-132.38
Net Income	-174.03	-223.46	-237.03	-191.69	-122.66	-143.65
Earnings Per Share	-0.64	-0.82	-0.87	-0.70	-0.45	-0.54
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
The Prc	180.75	128.77	201.95	163.19
Australia	181.55	179.63	148.23	62.14
Inter-segment	-	-75.13	-51.07	-17.36
Total	287.17	233.27	299.11	207.98

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	378.43	445.52	687.16	945.71	1,333	1,524
Total Debt	342.35	343.36	328.42	281.92	75.54	48.57
Net Cash (Debt)	36.08	102.16	358.74	663.8	1,258	1,476
Net Cash Growth	-64.68%	-71.52%	-45.96%	-47.23%	-14.75%	811.97%
Net Cash Per Share	0.13	0.37	1.31	2.43	4.60	5.56

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	-167.88	-229.12	-267.23	-188.77	-197.85
Capital Expenditures	-	-85.57	-93.3	-104.21	-128.45	-28.9
Free Cash Flow	-	-253.45	-322.41	-371.44	-317.22	-226.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	53.61%	52.99%	45.54%	43.92%	42.25%	47.67%
Operating Margin	-55.64%	-90.36%	-89.53%	-116.20%	-153.33%	-123.38%
Pretax Margin	-68.43%	-97.39%	-80.35%	-94.40%	-89.86%	-117.19%
Profit Margin	-66.76%	-95.79%	-79.25%	-92.17%	-87.06%	-133.88%
FCF Margin	-	-108.65%	-107.79%	-178.60%	-225.14%	-211.33%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1.23	1.96	2.36	2.81	6.41	13.91